Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 16,650 shares at $1.75 ($29K) on 2024-05-17, disclosed to the SEC on 2024-05-20.
Seasonal sale ($29k) by President & CEO — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-11-25 | $240K | — | Filing → |